Global burden of 87 risk factors in 204 countries and territories, 19902019: a systematic analysis for the Global Burden of Disease study 2019
There was no association observed for GLP1 receptor agonist use with an increased risk for thyroid cancer (hazard ratio, 0.93
However, animal studies indicate a potential risk to the fetus (unborn baby)
This overlap makes it challenging to determine whether observed cases represent a true drug effect or reflect the underlying patient population's inherent susceptibility
NAD(+) in aging, metabolism, and neurodegeneration
It is frequently catalogued alongside research peptides, but its chemistry, handling, and solubility profile differ from peptide reference standards